Author: Harika Pingali1, Stacy D Hunter2
1 Texas State University Department of Health & Human Performance, San Marcos, TX, USA.
2 Texas State University Department of Health & Human Performance, San Marcos, TX, USA. Electronic address: firstname.lastname@example.org.
Conference/Journal: Auton Neurosci
Date published: 2022 Nov 14
Other: Volume ID: 244 , Pages: 103050 , Special Notes: doi: 10.1016/j.autneu.2022.103050. , Word Count: 311
Hypertension is a widespread disease that, if persistent, increases the risks of coronary heart disease mortality and morbidity. Slow breathing is a recommended blood pressure-lowering strategy though the mechanisms mediating its effects are unknown.
This review aims to evaluate autonomic and vascular function as potential mediators driving BP adaptive responses with slow breathing.
We searched EBSCO host, Web of Science, Cochrane Central Register of Controlled Trials, and PubMed using key words for optimized search results.
Nineteen studies were included in this review (11 device-guided; 8 non-device-guided breathing). Though some studies showed increased vagally mediated components of heart rate variability during slow breathing, results from acute and long-term studies were incongruent. Increases in baroreflex sensitivity (BRS) following a single device-guided slow breathing bout were noted in normotensive and hypertensive adults. Long-term (4 weeks to 3 months) effects of slow breathing on BRS were absent. Device-guided breathing resulted in immediate reductions in muscle sympathetic nerve activity (MSNA) in normo- and hyper-tensive adults though results from long-term studies yielded inconsistent findings. Non-device-guided slow breathing posed acute and chronic effects on vascular function with reductions in arterial stiffness in adults with type I diabetes and increases in microvascular endothelial function in adults with irritable bowel syndrome. Non-device guided breathing also reduced pro-inflammatory cytokines in healthy and hypertensive adults in acute and chronic studies. No adverse effects or non-adherence to treatment were noted in these trials.
Device-guided slow breathing is a feasible and effective modality in improving BRS, HRV, and arterial stiffness though its long-term effects are obscure. Though less evidence exists supporting the efficacy of non-device-guided slow breathing, acute and chronic studies demonstrate improvements in vascular function and inflammatory cytokines. More studies are needed to further explore the long-term effects of slow breathing in general and non-device-guided breathing in particular.
Keywords: Heart rate variability; Inflammation; Pranayama; Slow breathing; Sympathetic activity.
PMID: 36410208 DOI: 10.1016/j.autneu.2022.103050